Tarsons Products Limited

Web: tarsons.com NSE: TARSONS BSE: 543399 SECTOR: Healthcare - Healthcare Equipment & Supplies

316 10(3%)

Volume

1L as on 23, Jun

Open

394

High

399

Low

393

306

VWAP

265

52 Week High

395

52 Week Low

164

Viand Research Rating

Quality Score

0/100

Growth Score

36/100

Valuation Score

50/100

Momentum Score

45/100

Analyst Recommendations

BUY/SELL

Hold | Buy | Strong Buy

Analyst Price Target

Market Cap (cr)

1,681

No. of Shares

5.32

P/E

45.35

P/B

3.53

Face Value

Div. Yield

Book Value (TTM)

CASH

DEBT

EPS (TTM)

ROE

7.78

ROCE

Profit Growth

Listing Date

26-Nov-21

Promoter Holding

47.3%

FII Holding

0.87%

DII Holding

0.19%

Price Chart

Price Performance

1 Week10%

1 Month20%

3 Months48%

6 Months35%

1 Year35%

YTD35%

Moving Average

5 Day SMA268

10 Day SMA240

20 Day SMA226

30 Day SMA221

50 Day SMA219

61 Day SMA212

80 Day SMA0

200 Day SMA0

PIVOT LEVEL

	Standard	Camarilla	Fibonacci	Woodie's
Resistance 3	285	273	278	288
Resistance 2	278	272	274	280
Resistance 1	274	271	272	278
Pivot Point	268	270	268	270
Support 1	264	269	264	267
Support 2	258	269	262	259
Support 3	254	268	258	257

Competitors/Peers

#	Symbol	MCAP	LTP	1W	1M	6M	1Y	P/E	Ind PE	Debt/Eq	NP Qtr Rs.Cr.
1	SUNPHARMA	4,68,099	1951	0%	4%	19%	16%	37	57.7	0.07	11509
2	DIVISLAB	1,93,792	7300	2%	9%	22%	11%	69	57.7	0	2568
3	TORNTPHARM	1,70,907	5050	0%	13%	25%	42%	72	57.7	1.79	2138
4	APOLLOHOSP	1,27,264	8851	0%	6%	31%	21%	58	57.7	0.9	2003
5	CIPLA	1,12,694	1395	2%	0%	3%	4%	22	57.7	0.02	3862
6	ZYDUSLIFE	1,10,623	1109	3%	4%	27%	17%	20	57.7	0.46	5124
7	LUPIN	1,09,686	2399	3%	3%	11%	25%	23	57.7	0.29	5355
8	MANKIND	1,05,603	2557	0%	0%	18%	3%	49	57.7	0.39	1938
9	MAXHEALTH	1,05,114	1080	2%	1%	8%	14%	0	57.7	0.32	1442
10	DRREDDY	97,638	1170	4%	8%	3%	5%	20	57.7	0.2	4158
Load More

Shareholding Pattern (%)

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023	Jun 2023	Mar 2023	Dec 2022	Sep 2022	Jun 2022	Mar 2022	Dec 2021
Promoters	(0.01) 47.30%	(0.01) 47.30%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.31%	(0.01) 47.30%
FIIs	(-1.61) 0.87%	(-3.41) 2.46%	(-3.31) 5.82%	(-0.41) 9.14%	(2.01) 9.53%	(-0.51) 7.51%	(0.11) 8.04%	(-0.21) 7.95%	(1.31) 8.16%	(-1.01) 6.83%	(-0.81) 7.85%	(-0.51) 8.64%	(-0.41) 9.16%	(-0.31) 9.60%	(0.61) 9.90%	(0.21) 9.33%	(-0.21) 9.12%	(0.01) 9.33%
DIIs	(0.21) 0.19%	(-0.11) 0.00%	(0.01) 0.08%	(-0.31) 0.04%	(-0.21) 0.30%	(0.31) 0.51%	(0.11) 0.21%	(-0.11) 0.11%	(-2.41) 0.17%	(-0.61) 2.60%	(-4.21) 3.15%	(-1.11) 7.38%	(-0.11) 8.45%	(0.41) 8.52%	(0.11) 8.13%	(0.31) 8.06%	(1.41) 7.76%	(0.01) 6.33%
Public	51.65%	50.23%	46.79%	43.50%	42.89%	44.69%	44.45%	44.63%	44.36%	43.27%	41.68%	36.67%	35.09%	34.59%	34.67%	35.31%	35.82%	37.04%
No. of Shareholders	84,093	87,336	88,966	90,891	93,417	96,927	99,586	105,330	102,866	107,564	108,236	107,440	105,304	107,945	107,011	112,227	125,714	159,891

Quarterly Results

	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Mar 2022	Dec 2021	Sep 2021	Jun 2021	Mar 2021	Dec 2020
Sales	120.93	107.89	102.33	91.36	112.69	95.68	99.25	84.8	105.72	61.79	84.94	70.66	76.05	69.15	67.56	60.23
Sales Growth % (YoY)	7.3%	12.8%	3.1%	7.7%	6.6%	54.8%	-	-	-	-	25.7%	17.3%	-	-	-	-
Sales Growth % (QoQ)	12.1%	5.4%	12%	-18.9%	17.8%	-3.6%	17%	-19.8%	71.1%	-27.3%	20.2%	-7.1%	10%	2.4%	12.2%	-
Expenses	86.66	76.37	74.88	66.66	75.67	66.04	73.94	66.04	75.48	38.91	40.61	37.52	37.58	32.39	32.71	29.56
Operating Profit	34.27	31.52	27.45	24.7	37.02	29.64	25.31	18.76	30.24	22.88	44.33	33.14	38.47	36.76	34.85	30.67
OPM %	28.34	29.21	26.82	27.04	32.85	30.98	25.5	22.12	28.6	37.03	52.19	46.9	50.59	53.16	51.58	50.92
Other Income	6.83	7.07	5.8	3.34	3.78	0.85	8.43	2.91	3.38	3.24	2.58	2.46	1.45	1.98	0.66	1.81
Interest	6.25	6.05	5.18	5.07	5.2	5.03	4.84	4.32	4.25	2.51	0.45	1.37	1.56	0.83	0.58	0.75
Depreciation	29.08	25.04	22.48	19.94	20.03	17.41	14.03	11.03	12.33	10.06	7.24	5.35	4.81	4.57	3.37	3.46
Profit before tax	5.77	7.5	5.59	3.03	15.57	8.05	14.87	6.32	17.04	13.55	39.22	28.88	33.55	33.34	31.56	28.27
Tax %	27.56	32.93	40.61	41.25	34.49	34.66	30.8	36.39	39.5	26.72	24.89	25.66	25.78	25.52	25.35	25.54
Net Profit	4.18	5.04	3.32	1.78	10.2	5.26	10.29	4.02	10.32	9.93	29.46	21.47	24.9	24.84	23.56	21.05
Net Profit Growth % (QoQ)	-17.1%	51.8%	86.5%	-82.5%	93.9%	-48.9%	156%	-61%	3.9%	-66.3%	37.2%	-13.8%	0.2%	5.4%	11.9%	-
Net Profit Growth % (YoY)	-59%	-4.2%	-67.7%	-55.7%	-1.2%	-47%	-	-	-	-	25%	2%	-	-	-	-
TTM Net Profit	14.32	20.34	20.56	27.53	29.77	29.89	34.56	24.27	20.25	9.93	100.67	94.77	94.35	69.45	44.61	0
EPS in Rs	0.79	0.95	0.62	0.33	1.92	0.99	1.93	0.76	1.94	1.87	5.54	4.04	4.89	4.88	1225.81	1095.21

Profit and Loss

	Mar 2026	Mar 2025	Mar 2024	Mar 2022	Mar 2021
Sales	423	392	296	301	229
Sales Growth %	7.7%	32.4%	-	31.4%	-
Expenses	305	282	196	148	125
Operating Profit	118	111	100	153	103
OPM %	28	28	34	51	45
Other Income	23	16	11	8	5
Interest	23	20	10	4	3
Depreciation	97	62	40	22	14
Profit before tax	22	45	61	135	92
Tax %	35	34	30	25	25
Net Profit	14	30	43	101	69
Net Profit Growth %	-53.3%	-30.2%	-57.4%	46.4%	-
EPS in Rs	2.69	5.6	8.01	18.92	3583.25
Dividend Payout %	0	0	25	0	0

Cash Flows

	Mar 2026	Mar 2025	Mar 2024	Mar 2022	Mar 2021
Cash from Operating Activity	118	114	103	83	68
Cash from Investing Activity	-130	-145	-285	-138	-64
Cash from Financing Activity	9	39	136	130	-27
Net Cash Flow	-3	8	-47	75	-23

Balance Sheet

	Mar 2026	Sep 2025	Mar 2025	Sep 2024	Mar 2024	Mar 2022	Mar 2021
Equity Capital	11	11	11	11	11	11	0.19
Reserves	624	616	620	603	602	479	244
Borrowings	393	396	339	317	269	22	34
Other Liabilities	158	141	111	123	90	33	18
Total Liabilities	1186	1164	1080	1054	972	544	296
Fixed Assets	733	583	536	480	336	189	120
CWIP	159	251	233	217	267	32	22
Investments	0	0	0	0	0	0	0
Other Assets	295	330	311	357	369	323	153
Total Assets	1186	1164	1080	1054	972	544	296

Delivery

#	Date	198 66% 329	Value (Cr)	Q/T 70	Del 37	Del 12
1	22-Jul	306	16	51	26	4
2	21-Jul	312	219	70	6	12
3	20-Jul	281	2	33	51	1
4	17-Jul	287	4	39	53	2
5	16-Jul	300	3	27	46	1
6	15-Jul	298	3	34	58	2
7	14-Jul	309	6	37	46	3
8	13-Jul	316	18	47	40	7
9	10-Jul	303	9	36	37	3
10	9-Jul	289	4	42	32	1
11	8-Jul	290	12	41	25	3
12	7-Jul	296	60	55	10	6
13	6-Jul	293	245	95	6	15
14	3-Jul	267	3	31	32	1
15	2-Jul	265	2	33	37	1
16	1-Jul	262	3	28	42	1
17	30-Jun	268	7	42	29	2
18	29-Jun	260	3	38	40	1
19	25-Jun	259	2	37	33	1
20	24-Jun	258	2	44	40	1
21	23-Jun	263	3	37	48	2
22	22-Jun	270	7	54	51	3
23	19-Jun	263	8	58	33	2
24	18-Jun	267	49	65	14	7
25	17-Jun	278	619	122	4	25
26	16-Jun	239	101	76	9	9
27	15-Jun	207	2	43	64	1
28	12-Jun	205	1	38	70	1
29	11-Jun	201	2	38	54	1
30	10-Jun	207	1	26	51	0
31	9-Jun	216	2	34	48	1
32	8-Jun	207	1	34	41	0
33	5-Jun	211	1	35	57	0
34	4-Jun	211	1	40	49	1
35	3-Jun	206	1	39	48	0
36	2-Jun	208	1	53	68	1
37	1-Jun	209	1	50	41	1
38	29-May	209	7	72	52	4
39	27-May	215	2	33	56	1
40	26-May	221	9	56	46	4
41	25-May	215	45	77	23	10
42	22-May	219	5	71	61	3
43	21-May	211	1	30	63	0
44	20-May	213	1	31	42	0
45	19-May	211	1	23	55	1
46	18-May	205	1	18	50	1
47	15-May	207	1	28	49	1
48	14-May	214	1	46	56	1

Daily Market Cap

Date	Total Market Cap	Change	Chg %
23-Jul	1,681c	49c	2.98
22-Jul	1,633c	38c	2.28
21-Jul	1,671c	137c	8.91
17-Jul	1,534c	68c	4.25
16-Jul	1,602c	12c	0.73
15-Jul	1,614c	35c	2.10
14-Jul	1,648c	41c	2.44
13-Jul	1,690c	137c	8.81
10-Jul	1,553c	14c	0.92
09-Jul	1,539c	4c	0.24
08-Jul	1,535c	50c	3.17
07-Jul	1,585c	28c	1.79
06-Jul	1,557c	169c	12.15
02-Jul	1,389c	45c	3.15
30-Jun	1,434c	67c	4.86
29-Jun	1,367c	18c	1.31
26-Jun	1,386c	36c	2.64
25-Jun	1,350c	26c	1.87
24-Jun	1,376c	34c	2.40
23-Jun	1,409c	25c	1.71
22-Jun	1,434c	20c	1.41
19-Jun	1,414c	7c	0.47
18-Jun	1,421c	37c	2.54
17-Jun	1,458c	170c	13.16
16-Jun	1,288c	197c	18.10
15-Jun	1,091c	0	0
12-Jun	1,091c	12c	1.06
11-Jun	1,102c	21c	1.88
10-Jun	1,124c	0	0

Stock Checklist

Price is above from 52 week high low average: 31%

Stock is trading above all short term SMAs: YES

Stock is trading above all long term SMAs: YES

Stock is Consistently Improving Long Term: NO

FII purchased in last quarter: NO

Promoters are buying the stock: NO

Mutual Fund Holdings

Held by 4 fund scheme(s) across 2 fund house(s) as of Jul26 · Total value ₹0 Cr · 0 increasing / 0 decreasing · View in MF Pro →

Fund House	Schemes	Weight %	Change	Value (Cr)
Bandhan Mutual Fund	2	0.02%	-	0
Motilal Oswal Mutual Fund	2	0.00%	-	0

Tarsons Products Limited

Price Chart

Price Performance

Moving Average

PIVOT LEVEL

Competitors/Peers

Shareholding Pattern (%)

Quarterly Results

Profit and Loss

Cash Flows

Balance Sheet

Delivery

Daily Market Cap

Stock Checklist

Mutual Fund Holdings

Strategy Builder

Bulk Deals

Events

News

Exchange Filings

Annual Reports

Ratings & Research Reports

Concalls

Announcements